Literature DB >> 7438333

Baroreceptor function in spontaneously hypertensive rats. Effect of preventing hypertension.

M C Andresen, A M Brown.   

Abstract

In the previous paper we showed that baroreceptor resetting in spontaneously hypertensive rats (SHR) resulted from an incomplete matching of increased receptor strain sensitivity with reduced vessel wall distensibility. Here SHR and Wister-Kyoto controls were treated with antihypertensive drugs in their drinking water (reserpine, hydrochlorothiazide, and hydralazine) from 5 weeks of age so that we might examine the role of blood pressure in the SHR vessel wall-receptor mismatch. Radius and receptor properties were measured using the in vitro aortic arch-aortic nerve preparation at 8, 14, 20, and 30 weeks. We found that baroreceptors from SHR with normal blood pressures had normal pressure thresholds and suprathreshold pressure sensitivities. However, the treated SHR receptors still had lower strain thresholds and the aortas still were less distensible than were the normal. Now, however, the increased receptor sensitivity was sufficient to normalize the relationship between baroreceptor function and arterial blood pressure. We conclude that, although blood pressure may be restored to normotensive levels by therapy, vascular abnormalities may continue to develop.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438333     DOI: 10.1161/01.res.47.6.829

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  2 in total

1.  Nociceptive pulmonary-cardiac reflexes are altered in the spontaneously hypertensive rat.

Authors:  J Shane Hooper; Katherine R Stanford; Pierina A Alencar; Natascha G Alves; Jerome W Breslin; Jay B Dean; Kendall F Morris; Thomas E Taylor-Clark
Journal:  J Physiol       Date:  2019-05-30       Impact factor: 5.182

2.  Role of musclin in the pathogenesis of hypertension in rat.

Authors:  Ying-Xiao Li; Kai-Chun Cheng; Akihiro Asakawa; Ikuo Kato; Yuki Sato; Haruka Amitani; Namiko Kawamura; Juei-Tang Cheng; Akio Inui
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.